Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Teng-Teng Chung"'
Autor:
Anand Velusamy, Angela F. Brady, Joseph Carlow, Huw Dorkins, Rebecca Igbokwe, Benjamin Whitelaw, Teng-Teng Chung, Rachel Harrison, Fiona Lalloo, Paul Brennan, Louise Izatt, Schaida Schirwani, Alan Kelsall, Barbara McGowan, Sophie T Williams, Rosemarie Davidson, Paul V. Carroll, Nicola Tufton, Patrick J. Morrison, Soo-Mi Park, Christopher Bowles, John Newell-Price, Julian Adlard, Monika Kosicka-Slawinska, Eamonn R. Maher, Richard M. Martin, Lara Hawkes, Rebecca Dyer, Scott Akker, Rupert Obholzer, Florian Wernig, Tricia Tan, Ruth T Casey, Prodromos Chatzikyriakou, Gemma White, Anna L. Mitchell, Mary Porteous
Publikováno v:
Clinical endocrinologyREFERENCES. 96(4)
Objective Phaeochromocytomas and paragangliomas (PPGL) are rare, but strongly heritable tumours. Variants in succinate dehydrogenase (SDH) subunits are identified in approximately 25% of cases. However, clinical and genetic information of patients wi
Publikováno v:
Clinical Endocrinology. 71:86-91
Summary Aims To evaluate the long-term efficacy and safety of pegvisomant as a treatment for acromegaly. Design Retrospective analysis of clinical and trial data from all patients treated with pegvisomant since 1997 at two centres with common protoco
Autor:
John P. Monson, G. M. Besser, Ashley B. Grossman, D. M. Walker, Jane Evanson, W. M. Drake, Scott Akker, Teng-Teng Chung
Publikováno v:
Clinical endocrinology. 68(6)
Summary Background Published data suggest that growth hormone replacement (GHR) may be given safely to patients with hypopituitarism consequent upon a pituitary/peripituitary tumour. However, a preponderance of patients treated with external pituitar
Autor:
Jane Evanson, Teng-Teng Chung, W. M. Drake, G. M. Besser, S. L. Chew, Ashley B. Grossman, D. M. Walker, John P. Monson, Piers N. Plowman
Publikováno v:
Clinical endocrinology. 63(3)
Summary Objective GH replacement is widely used in the management of patients with adult-onset (AO)-GH deficiency (GHD). In most cases, AO-GHD arises as a result of pituitary/peripituitary tumours and/or their treatment, but the effect of GH replacem